Viromed Medical GmbH acquired Fonterelli SPAC 2 AG (DUSE:Q11) in a reverse merger deal on November 17, 2022. The Perbandt family, the owner of the Viromed Group 68% of the new company, Viromed Medical AG. Thorsten Kuthe and Stefan Westerheide of Heuking Kühn Lüer Wojtek acted as legal advisor to Viromed Medical GmbH.

Viromed Medical GmbH acquired Fonterelli SPAC 2 AG (DUSE:Q11) in a reverse merger deal on November 17, 2022.